Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study on Fat Retention When Using the AuraGen 1-2-3™ With AuraClens™ System in Processing of Lipoaspirate for Autologous Fat Grafting to the Breast

NCT05258305 is registered in ClinicalTrials.gov with Tiger Biosciences, LLC. as lead sponsor.

NCT NCT05258305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05258305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study on Fat Retention When Using the AuraGen 1-2-3™ With AuraClens™ System in Processing of Lipoaspirate for Autologous Fat Grafting to the Breast
Lead sponsor
Tiger Biosciences, LLC.
Phase
Not applicable
Overall status
Completed
Start date
May 5, 2022
Completion date
January 8, 2025
Enrollment
200 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

breast fat grafting retention